TIDES, USA

COVID-19 update: TIDES 2020 has been rescheduled to take place on 15–18 September at the Hynes Convention Center (MA, USA). Click here to visit the TIDES 2020 website for the latest information.

Referred to as one of the largest meetings to accelerate oligonucleotide and peptide products from early discovery to late-stage development and commercialization, TIDES 2020 is including more technical presentations and data to be presented than previous years.

This year, the oligonucleotide track highlights include:

• How Ionis is identifying and avoiding RNAase H mediated off target events
• Sirnaomics’ siRNA therapeutics for oncology indications
• Biogen’s experience transitioning a biologics facility to include oligonucleotides
• Building Alnylam’s internal manufacturing capabilities
• Ajinomoto’s scalable manufacturing using a novel enzymatic approach
• Roche’s approach to microbial contaminant control

The peptide track highlights include:

• Brad Pentelute’s approach to protein manufacturing in hours
• Eli Lilly’s nasal glucagon program and device development
• AstraZeneca’s Bydureon BCise Device development/integration and formulation
• Neon’s personalized peptide vaccine
• Polypeptide’s investigation and control of peptide process-related impurities
• Novo Nordisk’s MedChem Strategies for PYY
  

  ---

You might also like…

The exciting world of oligonucleotides – how far have we come?

---

New for 2020:

• partneringONE System for pre-scheduling meetings
• Expanded genome editing track
• More case studies of mRNA therapeutic discovery, clinical and CMC
• Expanded delivery sessions covering oligos, peptides, mRNA and genome editing
• More in-depth peptide content and speakers
• More technical presentations with new data

For more information visit the TIDES 2020 website.